ConductScience.org, home

Paper35575255

Chemical Approaches to Synthetic Drug Delivery Systems for Systemic Applications.

Braatz D and 9 others. Angew Chem Int Ed Engl, 2022. Cited by 46 papers, by iCite.

Cite this record

ConductScience Library. Chemical Approaches to Synthetic Drug Delivery Systems for Systemic Applications. Papers, record 35575255. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35575255

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Chemical Approaches to Synthetic Drug Delivery Systems for Systemic Applications.
PubMed
Journal
Angew Chem Int Ed Engl
PubMed
Year
2022
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
46
iCite
Relative citation ratio, by iCite
3.8
iCite
Revised in PubMed
2024-09-16
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Braatz DDaniel
2Cherri MMariamhttps://orcid.org/0000-0001-8356-0860
3Tully MMichael
4Dimde MMathias
5Ma GGuoxin
6Mohammadifar EEhsanhttps://orcid.org/0000-0001-5720-5080
7Reisbeck FFelix
8Ahmadi VVahid
9Schirner MMichael
10Haag RRainerhttps://orcid.org/0000-0003-3840-162X

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Drug Delivery SystemsMajor topic
PolymersMajor topic
Solubility
Pharmaceutical Preparations
Water

References234

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117636564Mechanism of action of certolizumab pegol (CDP870): in vitro comparison with other anti-tumor necrosis factor alpha agents.Inflamm Bowel Dis2007https://conductscience.org/library/papers/17636564PubMed
216219368Evaluation of dendrimer SPL7013, a lead microbicide candidate against herpes simplex viruses.Antiviral Res2005https://conductscience.org/library/papers/16219368PubMed
321818161Stability of Self-Assembled Polymeric Micelles in Serum.Macromolecules2011https://conductscience.org/library/papers/21818161PubMed
429313017Anticancer nanoparticulate polymer-drug conjugate.Bioeng Transl Med2016https://conductscience.org/library/papers/29313017PubMed
511335787Phase I clinical and pharmacokinetic study of PNU166945, a novel water-soluble polymer-conjugated prodrug of paclitaxel.Anticancer Drugs2001https://conductscience.org/library/papers/11335787PubMed
618680439Application of dendrimer-drug complexation in the enhancement of drug solubility and bioavailability.Expert Opin Drug Metab Toxicol2008https://conductscience.org/library/papers/18680439PubMed
7405385Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol.J Biol Chem1977https://conductscience.org/library/papers/405385PubMed
810699287Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review.J Control Release2000https://conductscience.org/library/papers/10699287PubMed
927439953A Modular Method for the High-Yield Synthesis of Site-Specific Protein-Polymer Therapeutics.Angew Chem Int Ed Engl2016https://conductscience.org/library/papers/27439953PubMed
1018475293Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer.Br J Cancer2008https://conductscience.org/library/papers/18475293PubMed
1121040218Improved anti-tumor activity of stabilized anthracycline polymeric micelle formulation, NC-6300.Cancer Sci2011https://conductscience.org/library/papers/21040218PubMed
1219671439ProLindac (AP5346): a review of the development of an HPMA DACH platinum Polymer Therapeutic.Adv Drug Deliv Rev2009https://conductscience.org/library/papers/19671439PubMed
1333792290Polyglycerol for Half-Life Extension of Proteins-Alternative to PEGylation?Biomacromolecules2021https://conductscience.org/library/papers/33792290PubMed
1423020861Influence of architecture of high molecular weight linear and branched polyglycerols on their biocompatibility and biodistribution.Biomaterials2012https://conductscience.org/library/papers/23020861PubMed
1527369864Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation.J Control Release2016https://conductscience.org/library/papers/27369864PubMed
1616862189Drug penetration in solid tumours.Nat Rev Cancer2006https://conductscience.org/library/papers/16862189PubMed
1719084037Polymersome delivery of siRNA and antisense oligonucleotides.J Control Release2009https://conductscience.org/library/papers/19084037PubMed
1821297034Sortase-catalyzed transformations that improve the properties of cytokines.Proc Natl Acad Sci U S A2011https://conductscience.org/library/papers/21297034PubMed
1931310511Enzyme-Activatable Interferon-Poly(α-amino acid) Conjugates for Tumor Microenvironment Potentiation.Biomacromolecules2019https://conductscience.org/library/papers/31310511PubMed
2024056901Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology.Nat Nanotechnol2013https://conductscience.org/library/papers/24056901PubMed

See all 234 referencesDownload CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 46 citations.

PMIDTitleJournalYearIn PapersSource
42259798Supercharged ferritin nanocages enable universal cytosolic protein delivery.Nat Commun2026https://conductscience.org/library/papers/42259798PubMed
42204141Combating small extracellular vesicle-mediated immunological barriers in the tumor microenvironment via strategically activatable PEGylated peptides.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42204141PubMed
41477338Site-specific PEGylation of proteins: Insights into structural and functional changes.Acta Pharm Sin B2025https://conductscience.org/library/papers/41477338PubMed
40565229Peptide-Engineered Seliciclib Nanomedicine for Brain-Targeted Delivery and Neuroprotection.Int J Mol Sci2025https://conductscience.org/library/papers/40565229PubMed
40459969Hydration Contribution to the Solvation Free Energy of Water-Soluble Polymers.J Phys Chem B2025https://conductscience.org/library/papers/40459969PubMed
39959040Novel Maleimide Linkers Based on a Piperazine Motif for Strongly Increased Aqueous Solubility.ACS Omega2025https://conductscience.org/library/papers/39959040PubMed
39664427Solubilization techniques used for poorly water-soluble drugs.Acta Pharm Sin B2024https://conductscience.org/library/papers/39664427PubMed
39642424Advances in acid-degradable and enzyme-cleavable linkers for drug delivery.Curr Opin Chem Biol2025https://conductscience.org/library/papers/39642424PubMed
39493304Extracellular vesicle mimetics as delivery vehicles for oligonucleotide-based therapeutics and plasmid DNA.Front Bioeng Biotechnol2024https://conductscience.org/library/papers/39493304PubMed
38543448Polymer-Based Drug Delivery Systems for Cancer Therapeutics.Polymers (Basel)2024https://conductscience.org/library/papers/38543448PubMed
38333874
d-α-tocopheryl polyethylene glycol 1000 succinate surface scaffold polysarcosine based polymeric nanoparticles of enzalutamide for the treatment of colorectal cancer: In vitro, in vivo characterizations.
Heliyon2024https://conductscience.org/library/papers/38333874PubMed
37908727Peptide-drug co-assembling: A potent armament against cancer.Theranostics2023https://conductscience.org/library/papers/37908727PubMed
37836823Optimization and Characterization of Sodium Alginate Beads Providing Extended Release for Antidiabetic Drugs.Molecules2023https://conductscience.org/library/papers/37836823PubMed
37765191Hyperbranched Polymers: Recent Advances in Photodynamic Therapy against Cancer.Pharmaceutics2023https://conductscience.org/library/papers/37765191PubMed
37563117Applied machine learning as a driver for polymeric biomaterials design.Nat Commun2023https://conductscience.org/library/papers/37563117PubMed
37500621Precise cooperative sulfur placement leads to semi-crystallinity and selective depolymerisability in CS2/oxetane copolymers.Nat Commun2023https://conductscience.org/library/papers/37500621PubMed
37402278Polyglycerol-Based Biomedical Matrix for Immunomagnetic Circulating Tumor Cell Isolation and Their Expansion into Tumor Spheroids for Drug Screening.Adv Healthc Mater2023https://conductscience.org/library/papers/37402278PubMed
37261292Tailoring thermoresponsiveness of biocompatible polyethers: copolymers of linear glycerol and ethyl glycidyl ether.Polym Chem2023https://conductscience.org/library/papers/37261292PubMed
36771924Conformational Parameters and Hydrodynamic Behavior of Poly(2-Methyl-2-Oxazoline) in a Broad Molar Mass Range.Polymers (Basel)2023https://conductscience.org/library/papers/36771924PubMed
35575255Chemical Approaches to Synthetic Drug Delivery Systems for Systemic Applications.Angew Chem Int Ed Engl2022https://conductscience.org/library/papers/35575255PubMed

Download CSV of cited by

Genes22

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
BCL2L1598PubTator's text mininghttps://conductscience.org/library/genes/598NCBI Gene
CAT847PubTator's text mininghttps://conductscience.org/library/genes/847NCBI Gene
CSF31440PubTator's text mininghttps://conductscience.org/library/genes/1440NCBI Gene
CTSB1508PubTator's text mininghttps://conductscience.org/library/genes/1508NCBI Gene
FAP2191PubTator's text mininghttps://conductscience.org/library/genes/2191NCBI Gene
FOLH12346PubTator's text mininghttps://conductscience.org/library/genes/2346NCBI Gene
GH12688PubTator's text mininghttps://conductscience.org/library/genes/2688NCBI Gene
IFNA13439PubTator's text mininghttps://conductscience.org/library/genes/3439NCBI Gene
ITGAV3685PubTator's text mininghttps://conductscience.org/library/genes/3685NCBI Gene
KRAS3845PubTator's text mininghttps://conductscience.org/library/genes/3845NCBI Gene
LOC102724197102724197PubTator's text mininghttps://conductscience.org/library/genes/102724197NCBI Gene
LYZ4069PubTator's text mininghttps://conductscience.org/library/genes/4069NCBI Gene
PDC5132PubTator's text mininghttps://conductscience.org/library/genes/5132NCBI Gene
PKLR5313PubTator's text mininghttps://conductscience.org/library/genes/5313NCBI Gene
PROK260675PubTator's text mininghttps://conductscience.org/library/genes/60675NCBI Gene
RTN4R65078PubTator's text mininghttps://conductscience.org/library/genes/65078NCBI Gene
SST6750PubTator's text mininghttps://conductscience.org/library/genes/6750NCBI Gene
TFRC7037PubTator's text mininghttps://conductscience.org/library/genes/7037NCBI Gene
TNF7124PubTator's text mininghttps://conductscience.org/library/genes/7124NCBI Gene

See all 22 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35575255

GET https://conductscience.org/api/papers/v1/35575255/references?page=2